Sherwin-Williams (NYSE:SHW) Price Target Raised to $375.00 at Morgan Stanley

Sherwin-Williams (NYSE:SHW) had its price objective upped by Morgan Stanley from $345.00 to $375.00 in a report published on Tuesday morning, PriceTargets.com reports. The brokerage currently has an overweight rating on the specialty chemicals company’s stock.

Several other equities research analysts have also commented on the stock. Deutsche Bank Aktiengesellschaft raised their price target on shares of Sherwin-Williams from $320.00 to $355.00 and gave the company a buy rating in a research note on Wednesday, October 27th. Berenberg Bank upped their price target on shares of Sherwin-Williams from $278.00 to $310.00 and gave the company a hold rating in a research report on Friday, October 29th. UBS Group increased their target price on shares of Sherwin-Williams from $310.00 to $350.00 and gave the stock a neutral rating in a research report on Tuesday, January 4th. The Goldman Sachs Group downgraded shares of Sherwin-Williams from a buy rating to a neutral rating and set a $320.00 target price for the company. in a research report on Wednesday, December 15th. Finally, BMO Capital Markets cut Sherwin-Williams from an outperform rating to a market perform rating and boosted their price target for the stock from $355.00 to $376.00 in a research report on Tuesday, January 4th. Nine research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat.com, Sherwin-Williams has a consensus rating of Buy and an average price target of $357.73.

Shares of NYSE SHW opened at $308.46 on Tuesday. The stock has a market cap of $80.88 billion, a price-to-earnings ratio of 42.27, a PEG ratio of 2.42 and a beta of 1.07. The company has a current ratio of 0.83, a quick ratio of 0.55 and a debt-to-equity ratio of 2.83. The company’s 50-day moving average price is $334.90 and its 200 day moving average price is $308.81. Sherwin-Williams has a 52 week low of $218.06 and a 52 week high of $354.15.

Sherwin-Williams (NYSE:SHW) last announced its quarterly earnings data on Monday, October 25th. The specialty chemicals company reported $2.09 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.07 by $0.02. The business had revenue of $5.15 billion for the quarter, compared to analyst estimates of $5.09 billion. Sherwin-Williams had a net margin of 10.00% and a return on equity of 75.00%. The company’s revenue was up .5% on a year-over-year basis. During the same period in the prior year, the firm posted $2.76 EPS. As a group, research analysts expect that Sherwin-Williams will post 8.49 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 3rd. Shareholders of record on Friday, November 19th were given a dividend of $0.55 per share. This represents a $2.20 annualized dividend and a yield of 0.71%. The ex-dividend date was Thursday, November 18th. Sherwin-Williams’s dividend payout ratio is currently 30.15%.

Large investors have recently modified their holdings of the company. Colony Group LLC grew its stake in shares of Sherwin-Williams by 0.8% during the 3rd quarter. Colony Group LLC now owns 3,926 shares of the specialty chemicals company’s stock valued at $1,098,000 after purchasing an additional 31 shares during the period. Jacobi Capital Management LLC lifted its position in Sherwin-Williams by 5.1% during the third quarter. Jacobi Capital Management LLC now owns 682 shares of the specialty chemicals company’s stock valued at $191,000 after purchasing an additional 33 shares during the last quarter. Harbor Investment Advisory LLC lifted its position in Sherwin-Williams by 0.9% during the fourth quarter. Harbor Investment Advisory LLC now owns 3,772 shares of the specialty chemicals company’s stock valued at $1,328,000 after purchasing an additional 33 shares during the last quarter. Exchange Traded Concepts LLC lifted its holdings in shares of Sherwin-Williams by 1.7% in the 4th quarter. Exchange Traded Concepts LLC now owns 2,024 shares of the specialty chemicals company’s stock worth $713,000 after acquiring an additional 33 shares during the last quarter. Finally, Corient Capital Partners LLC lifted its holdings in shares of Sherwin-Williams by 1.1% in the 3rd quarter. Corient Capital Partners LLC now owns 3,346 shares of the specialty chemicals company’s stock worth $936,000 after acquiring an additional 36 shares during the last quarter. Hedge funds and other institutional investors own 76.52% of the company’s stock.

About Sherwin-Williams

The Sherwin-Williams Co engages in the manufacture and trade of paint and coatings. It operates through the following segments: America Group, Consumer Brands Group, and Performance Coating Group. The America Group segment manages the exclusive outlets for Sherwin-Williams branded paints, stains, supplies, equipment, and floor covering.

Recommended Story: How can investors invest in the S&P/TSX Index?

Analyst Recommendations for Sherwin-Williams (NYSE:SHW)

Receive News & Ratings for Sherwin-Williams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sherwin-Williams and related companies with MarketBeat.com's FREE daily email newsletter.